[August 15, 2008]

Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles

Company:               1-800-PetMeds
Ticker Symbol & Exchange:       PETS
Investor Relations Contact:      Bruce Rosenbloom
Investor Relations Contact Phone:   954-979-5995
Web:                 www.1800petmeds.com
Date of Presentation:         8/18/08
PetMed Express, Inc. d/b/a 1-800-PetMeds, is a leading nationwide pet
pharmacy. The Company markets prescription and non-prescription pet
medications, and other health products for dogs, cats, and horses
direct to the consumer. The Company offers consumers an attractive
alternative for obtaining pet medications in terms of convenience,
price, ease of ordering and speed of delivery.
The Company markets its products through national television, online,
and direct mail/print advertising campaigns, which direct the
consumers to order by phone or on the internet on its website at
www.1800petmeds.com, and aim to increase the recognition of the "1-
800-PetMeds" brand name.
Company:               Access Pharmaceuticals, Inc.
Ticker Symbol & Exchange:       ACCP.OB
Investor Relations Contact:      Stephen B. Thompson
Investor Relations Contact Phone:   214-905-5100
Web:                 www.accesspharma.com
Date of Presentation:         Monday, August 18, 2008
Access Pharmaceuticals, Inc. (ACCP.OB) is an emerging pharmaceutical
company focused on the development and commercialization of
proprietary products for the treatment and supportive care of cancer
patients. Access has one approved product, MuGard(TM) for the
management of oral mucositis. The company's lead oncology product is
ProLindac(TM), a polymer-linked platinum cancer drug, which is in
Phase 2 clinical testing in recurrent ovarian cancer patients.
Angiolix(R) an antiangiogenic humanized monoclonal antibody, and
Prodrax(R), a hypoxia-activated prodrug, are the company's lead
preclinical oncology products. Access is also developing oral insulin
and oral hGH using its proprietary Cobalamin(TM) oral drug delivery
technology.
Company:               Allion Healthcare
Ticker Symbol & Exchange:       ALLI / NASDAQ
Investor Relations Contact:      Rich Cockrell, The Cockrell
                   Group
Investor Relations Contact Phone:   404.942.3369
Web:                 www.allionhealthcare.com
Date of Presentation:         08.18.08
Allion Healthcare, Inc. is a national provider of specialty pharmacy
and disease management services focused on HIV/AIDS patients as well
as specialized biopharmaceutical medications and services to
chronically ill patients. Allion Healthcare sells HIV/AIDS
medications, ancillary drugs and nutritional supplies under the trade
name MOMS Pharmacy. Allion Healthcare provides services for the
intravenous immunoglobulin, Blood Clotting Factor and other therapies
through its Biomed America division. Allion Healthcare works closely
with physicians, nurses, clinics, AIDS Service Organizations, and
with government and private payors to improve clinical outcomes and
reduce treatment costs.
Company:               Alphatec Spine, Inc.
Ticker Symbol & Exchange:       ATEC
Investor Relations Contact:      Cheryl Monblatt
Investor Relations Contact Phone:   760 505 1785
Web:                 www.alphatecspine.com
Date of Presentation:         Monday, August 18
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company involved in the design, development, manufacturing and
marketing of products for the surgical treatment of spine disorders,
with a focus on treating disorders related to the aging spine. The
company's mission is to combine world-class customer service with
innovative, surgeon-driven design that will help improve the aging
patient's quality of life. The company is poised to achieve its goal
through new solutions for patients with osteoporosis and other aging
spine deformities, improved minimally invasive products and
techniques and integrated biologics solutions. In addition to its
U.S. operations, Alphatec Spine also markets its spine products in
Europe.
Company:               American CareSource Holdings,
                   Inc.
Ticker Symbol & Exchange:       AMEX: XSI
Investor Relations Contact:      Melody Carey
Investor Relations Contact Phone:   917-322-2571
Web:                 www.anci-care.com
Date of Presentation:         8/18/2008
American CareSource Holdings, the first national, publicly traded
ancillary care network services company offers a comprehensive
national network of approximately 2,500 ancillary service providers
at over 25,000 sites. The Company's ancillary network and management
provides a complete outsourced solution for a wide variety of
healthcare payors and plan sponsors including self-insured employers,
indemnity insurers, PPOs, HMOs, third party administrators and both
federal and local governments. For additional information, please
visit www.anci-care.com.
Company:               Baldwin Technology Company, Inc.
Ticker Symbol & Exchange:       AMEX: BLD
Investor Relations Contact:      Helen P. Oster
Investor Relations Contact Phone:   203 402 1004
Web:                 baldwintech.com
Date of Presentation:         8/19/2008
Baldwin is a leading global supplier of process automation systems and
associated consumables for the printing and publishing industry.
Baldwin's broad range of products are designed to enhance the
quality, productivity and cost-efficiency of the print manufacturing
process while addressing environmental concerns and safety issues.
Baldwin sells its products both to printers to upgrade the quality and
capability of their existing presses and to printing press
manufacturers who incorporate them into their own equipment.
Headquartered in Connecticut, Baldwin has product development and
production facilities, as well as a network of sales and service
operations, in strategic markets worldwide.
Company:               Ballantyne of Omaha, Inc.
Ticker Symbol & Exchange:       AMEX: BTN
Investor Relations Contact:      Ratula Roy/David Collins
Investor Relations Contact Phone:   212-835-8500
Web:                 roy@jcir.com
Date of Presentation:         Monday, Aug. 18, 2008; 11:30 a.m
                   PT
For over 70 years, Ballantyne (BTN) has built a commanding position
and strong customer relationships within the traditional cinema
projection market. Now armed with NEC's state-of-the art Starus(TM)
digital projector line, BTN's leading digital cinema service business
and cinema screens and other products, BTN is ideally positioned to
participate in the cinema industry's largest-ever capital spending
program: the conversion digital cinema technology.
Company:               BioScrip, Inc.
Ticker Symbol & Exchange:       BIOS Nasdaq
Investor Relations Contact:      Craig Allison - Lisa Wilson
Investor Relations Contact Phone:   914-460-1636 - 917-543-9932
Web:                 www.bioscrip.com
Date of Presentation:         8/19/2008
BioScrip is a specialty healthcare organization that partners with
patients, physicians, healthcare payors and pharmaceutical
manufacturers to provide access to medications and management
solutions to optimize outcomes for chronic and other complex
healthcare conditions.
Company:               BioSphere Medical, Inc.
Ticker Symbol & Exchange:       BSMD (NASDAQ)
Investor Relations Contact:      Kim Sutton Golodetz
Investor Relations Contact Phone:   212-838-3777
Web:                 www.biospheremed.com
Date of Presentation:         8/18/2008
BioSphere Medical, Inc. seeks to pioneer and commercialize minimally
invasive diagnostic and therapeutic applications based on proprietary
bioengineered microsphere technology. The Company's core
technologies, patented bioengineered polymers and manufacturing
methods, are used to produce microscopic spherical materials with
unique beneficial properties for a variety of medical applications.
BioSphere's principal focus is the treatment of symptomatic uterine
fibroids using a procedure called uterine fibroid embolization, or
UFE. The Company's products continue to gain acceptance in this
rapidly emerging procedure, as well as in a number of other new and
established medical treatments.
Company:               Bonds.com Group, Inc.
Ticker Symbol & Exchange:       (OTC:BDCG)
Investor Relations Contact:      Justin Davis
Investor Relations Contact Phone:   877-800-BDCG (2324)
Web:                 Justin.Davis@CirrusFC.com
Date of Presentation:         8/19/2008
Bonds.com Group, Inc., (OTC:BDCG) provides through its broker dealer
subsidiary, Bonds.com, Inc., an online fixed income trading platform,
BondStation. BondStation empowers self directed investors by
providing a competitive centralized marketplace for the usually
illiquid products such as Municipals, Corporates, Agencies, Emerging
Market Debt, Structured Products and CD's. The company differentiates
itself by offering 30,000 unique securities from 175+ competing
sources at no cost to its clients or liquidity providers. Market
research, investor tools, and fixed income educational tools are
provided at no fee to enhance the customer experience. Our goal is to
empower clients with unbiased market information and execution
capabilities.
Company:               CBIZ, Inc.
Ticker Symbol & Exchange:       CBZ
Investor Relations Contact:      Lori Novickis
Investor Relations Contact Phone:   216-525-1953
Web:                 www.cbiz.com
Date of Presentation:         8/18/2008
CBIZ, Inc. provides professional business services that help clients
better manage their finances, employees and technology. As the
largest benefits specialist, one of the largest accounting, valuation
and medical practice management companies in the United States, CBIZ
provides its clients with financial services which include accounting
and tax, internal audit, merger and acquisition advisory, and
valuation. Employee services include group benefits, property and
casualty insurance, payroll, HR consulting and wealth management.
CBIZ also provides information technology, hardware and software
solutions, healthcare consulting and medical practice management.
These services are provided throughout a network of more than 140
Company offices in 34 states.
Company:               CombiMatrix Corporation
Ticker Symbol & Exchange:       CBMX (Nasdaq)
Investor Relations Contact:      Amit Kumar, President & CEO
Investor Relations Contact Phone:   425-493-2000
Web:                 www.combimatrix.com
Date of Presentation:         8/18/2008
CombiMatrix Corporation is a biotechnology company headquartered near
Seattle, Washington, USA, with a subsidiary, CombiMatrix Molecular
Diagnostics, headquartered in Irvine, California. CombiMatrix's
patented electrochemical manufacturing process utilizes standard
semiconductor technology, proprietary software, and chemistry to
build arrays of materials -- molecule by molecule. The company's
CustomArray(TM) products are DNA microarrays, which have uses in
pharmaceutical, biotech, and agrochemical industries as well as in
research and government markets. The company also uses its technology
in synergistic internal programs for diagnostics development, drug
development, and biodefense in addition to partnerships for
nanomaterials development.
Company:               Continucare Corporation
Ticker Symbol & Exchange:       CNU:AMEX
Investor Relations Contact:      Fernando L. Fernandez
Investor Relations Contact Phone:   305-500-2105
Web:                 www.continucare.com
Date of Presentation:         8/19/2008
Continucare provides primary care physician services on an outpatient
basis through a network of medical facilities and independent
physician affiliates (IPAs) in the State of Florida. Continucare has
18 medical offices equipped with state-of-the-practice technology and
staffed with experienced physicians and a comprehensive support
staff. In addition, Continucare provides health practice management
services to IPAs who practice primary care medicine in South Florida.
Continucare assists these physicians with medical utilization and
pharmacy management and specialist network development, freeing them
to devote more time to patient care.
Company:               CSMG Technologies Inc.
Ticker Symbol & Exchange:       CTGI - OTCBB
Investor Relations Contact:      Michael Dodge
Investor Relations Contact Phone:   212.495.0744
Web:                 www.csmgtechinternational.com
Date of Presentation:         9/19/2008
CSMG Technologies, Inc. is an advanced technology management company
engaged in owning, developing, patenting, managing, licensing, and
marketing.
Live Tissue Connect Subsidiary
LTC's 400 VAD System, used in human surgery to bond / weld soft
tissue, replaces sutures, staples and glues, just received FDA
clearance.
Green Energy
CSMG recently acquired Carbon Capture Technologies owns worldwide
exclusive license to composition and method for use of novel Carbon
Dioxide (CO2) recyclable adsorbent based on surface modified
nanoporous silicas. Potential uses include C02 emissions from coal-
fired power plants and surgical applications.
CSMG's landfill gas technology separates carbon dioxide and other
impurities from gas produced in landfills.
Company:               CTG
Ticker Symbol & Exchange:       Nasdaq: CTGX
Investor Relations Contact:      James R. Boldt, CEO
Investor Relations Contact Phone:   (716) 888-3634
Web:                 www.ctg.com
Date of Presentation:         Tuesday, August 19
CTG provides IT solutions and services to help Global 2000 clients
focus on their core businesses and use IT as a competitive advantage
to excel in their markets. CTG combines in-depth understanding of our
clients' businesses with a full range of integrated services and
proprietary ISO 9001:2000-certified service methodologies. Our 3,500
IT professionals based in an international network of offices in
North America and Europe have a proven track record of delivering
high-value, industry-specific solutions.
Company:               Cytori Therapeutics, Inc.
Ticker Symbol & Exchange:       CYTX -- NASDAQ
Investor Relations Contact:      Tom Baker
Investor Relations Contact Phone:   858-458-0900
Web:                 www.cytoritx.com
Date of Presentation:         8/18/2008
Cytori's (NASDAQ: CYTX) goal is to be the global leader in
regenerative medicine. The company is dedicated to providing patients
with new options for reconstructive surgery, developing treatments
for cardiovascular disease, and banking patients' adult stem and
regenerative cells. The Celution(R) 800 System is being introduced in
Europe and Asia Pacific into the reconstructive surgery market while
the Celution(R) 900 System is being commercialized globally for
cryopreserving a patient's own stem and regenerative cells. Clinical
trials are ongoing in cardiovascular disease and planned for spinal
disc degeneration, gastrointestinal disorders, and other unmet
medical needs. www.cytoritx.com
Company:               EF Johnson Technologies, Inc.
Ticker Symbol & Exchange:       EFJI
Investor Relations Contact:      Jana Ahlfinger Bell
Investor Relations Contact Phone:   972-819-0700
Web:                 www.efji.com
Date of Presentation:         8/18/2008
Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses
on innovating, developing and marketing the highest quality secure
communications solutions to organizations whose mission is to protect
and save lives. The Company's customers include first responders in
public safety and public service, the federal government, and
industrial organizations. The Company's products are marketed under
the EFJohnson, 3e Technologies International, and Transcrypt
International trade names.
Company:               EMS Technologies, Inc.
Ticker Symbol & Exchange:       ELMG & NASDAQ
Investor Relations Contact:      Gary Shell
Investor Relations Contact Phone:   770-729-6512
Web:                 http://www.ems-t.com/
Date of Presentation:         Monday, August 18, 2008
EMS Technologies, Inc. (NASDAQ: ELMG) is a wireless and satellite
communication solutions leader, serving aeronautical, defense,
maritime, commercial space and supply chain markets. Through its LXE,
EMS SATCOM, and Defense & Space Systems divisions, EMS keeps people,
systems and data connected, wherever they are -- on the ground, in
the warehouse, in the air, or in space. The company is headquartered
in Atlanta, employs approximately 1,000 people worldwide and operates
major manufacturing facilities in Atlanta and Ottawa, Canada.
Company:               Etelos, Inc.
Ticker Symbol & Exchange:       OTCBB: ETLO
Investor Relations Contact:      Leslie Green
Investor Relations Contact Phone:   650-312-9060
Web:                 etelos.com
Date of Presentation:         9:30 AM Aug. 19, 2008
Etelos provides on-demand, customizable browser-based applications on
the hosting environment you choose. Etelos' patent-pending technology
for developing and deploying on-demand applications is
revolutionizing the world of software distribution. The Etelos
Marketplace gives developers an easy way to license, distribute and
host applications. It also gives businesses a wide selection of fully
customizable, on-demand applications to buy and deploy to the hosting
environment of their choice. The Etelos Ecosystem provides all of the
features of Software as a Service (SaaS) with all the flexibility of
custom development.
Company:               ev3 Inc.
Ticker Symbol & Exchange:       EVVV NASDAQ
Investor Relations Contact:      Julie Tracy Sr. Vice President
Investor Relations Contact Phone:   949-680-1375
Web:                 http://www.ev3.net
Date of Presentation:         8/18/2008
Since its founding in 2000, ev3 has been dedicated to developing
innovative, breakthrough and clinically proven technologies and
solutions for the treatment of lower extremity vascular and
neurovascular diseases. ev3's products are used by endovascular
specialists to treat a wide range of peripheral vascular and
neurovascular diseases and disorders. The company offers a
comprehensive portfolio of treatment options, including the primary
interventional technologies used today - peripheral angioplasty
balloons, stents, plaque excision systems, embolic protection
devices, liquid embolics, embolization coils, thrombectomy catheters
and occlusion balloons. More information about the company and its
products can be found at www.ev3.net.
Company:               Exactech
Ticker Symbol & Exchange:       Nasdaq EXAC
Investor Relations Contact:      Hawk Associates
Investor Relations Contact Phone:   Julie Marshall 305.451.1888
Web:                 www.hawkassociates.com and
                   www.exac.com
Date of Presentation:         8/18/2008
Exactech is a pure play orthopaedic competitor that is gaining market
share in the rapidly expanding global biomedical device industry. The
company's products are used in the restoration of bones and joints
that have deteriorated as a result of injury or disease such as
arthritis.
Exactech develops, manufactures, markets, distributes and sells its
orthopaedic implant devices, including knee, shoulder, and hip
implant systems, related surgical instrumentation and biologic
services to hospitals and physicians in the United States and
internationally in over 30 countries.
Founded and led by an orthopaedic surgeon, the company has built its
success on its customer-centric culture. Feedback and input from its
surgeon customers have helped Exactech develop a pipeline of
innovative products that improve patient outcomes.
Company:               EXL Service
Ticker Symbol & Exchange:       EXLS
Investor Relations Contact:      Jarrod Yahes
Investor Relations Contact Phone:   jarrod.yahes@exlservice.com
                   212.277.7109
Web:                 www.exlservice.com
ExlService Holdings, Inc. (Nasdaq: EXLS - News) is a leading provider
of Outsourcing and Transformation Services. EXL's Outsourcing
Services include a full spectrum of business process outsourcing
services from offshore delivery centers requiring ongoing process
management skills. Transformation Services enable continuous
improvement of client processes by bringing together EXL's
capabilities in reengineering including Six Sigma process
improvement, research & analytics, and risk advisory services.
Headquartered in New York, EXL primarily serves the needs of Global
1000 companies in the insurance, utilities, financial services,
healthcare, telecommunications and transportation sectors. Find
additional information about EXL at www.exlservice.com.
Company:               Full House Resorts
Ticker Symbol & Exchange:       FLL-AMEX
Investor Relations Contact:      Mark Miller
Investor Relations Contact Phone:   702-221-7800
Web:                 http://www.fullhouseresorts.com/
Date of Presentation:         Monday, August 18, 2008 12 pm PT
Full House owns, develops and manages gaming facilities. Full House
owns the Stockman's Casino in Fallon, Nevada which has 8,400 square
feet of gaming space with approximately 260 gaming machines, four
table games and a keno game. The Company also receives a guaranteed
fee from the operation of Harrington Raceway and Casino in
Harrington, Delaware. Full House also has a management agreement with
the Nottawaseppi Huron Band of Potawatomi Indians for the development
and management of a first-class casino/resort with 2,500 gaming
devices, 90 table games and 20 poker tables in the Battle Creek,
Michigan area - currently under construction.
Company:               Globex Mining Enterprises Inc.
Ticker Symbol & Exchange:       GMX-TSX, GLBXF-OTCQX
Investor Relations Contact:      Dan Symons from Renmark
Investor Relations Contact Phone:   514-939-3989, ext. 3323
Web:                 www.globexmining.com
Date of Presentation:         August 19th, 2008
Globex is a TSX listed Canadian royalty and exploration company with a
vast portfolio of wholly owned projects all within North America. The
company has few shares issued, cash in the bank and no debt. The
first quarter of 2008 saw the stat of significant royalty streams as
two mines reached production. Six others are in pre-production or due
diligence. Projects include: copper, zinc, gold, magnesium, talc,
nickel, platinum, palladium, uranium, rare earths and diamonds.
Company:               iLinc
Ticker Symbol & Exchange:       ILC
Investor Relations Contact:      James L. Dunn, Jr.
Investor Relations Contact Phone:   602-952-1200
Web:                 www.ilinc.com
Date of Presentation:         8/19/2008
iLinc, a recognized leader in web conferencing, desktop video
conferencing software and collaboration solutions, aims to
revolutionize the way organizations meet and communicate. Through its
software and services, iLinc liberates people by enabling them to get
more done, travel less, achieve work-life balance while preserving
the environment. iLinc offers the only enterprise-class web and video
conferencing software that allows customers to choose between a
software-as-a-service (SaaS) rental model or a traditional software
purchase model, in combination with hosting by iLinc or on-premise
installation. iLinc is headquartered in Phoenix, Arizona. For more
visit www.ilinc.com/investors.
Company:               Inspire Pharmaceuticals
Ticker Symbol & Exchange:       ISPH
Investor Relations Contact:      Jenny Kobin
Investor Relations Contact Phone:   919 287-1219
Web:                 www.inspirepharm.com
Date of Presentation:         8/18/2008
Inspire is a biopharmaceutical company dedicated to discovering,
developing and commercializing prescription pharmaceutical products
for ophthalmic and pulmonary diseases. Inspire employs a U.S. sales
force for the promotion of AzaSite(R) (azithromycin ophthalmic
solution) 1% for bacterial conjunctivitis, Elestat(R) (epinastine HCI
ophthalmic solution) 0.05% for allergic conjunctivitis and
Restasis(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye.
Inspire is currently developing products for dry eye, cystic fibrosis
and glaucoma. Elestat, Restasis and Prolacria are trademarks owned by
Allergan, Inc. AzaSite is a trademark owned by InSite Vision
Incorporated. For more information, visit www.inspirepharm.com.
Company:               KRATOS DEFENSE & SECURITY
                   SOLUTIONS, INC
Ticker Symbol & Exchange:       NASDAQ: KTOS
Investor Relations Contact:      MICHAEL BAEHR, VP of IR
Investor Relations Contact Phone:   (858) 812-7366
Web:                 WWW.KRATOSDEFENSE.COM
Date of Presentation:         AUG. 18
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) is a leading
national defense, information technology and homeland security
solutions provider. The Company primarily performs work for the U.S.
federal government, but also for various state and local agencies.
Principle services include C5ISR, weapon systems life cycle support,
military range operations and technical services, missile, rocket and
weapon systems test & evaluation, advanced network engineering and IT
services, security and surveillance integration, and critical
infrastructure design and integration. The Company is headquartered
in San Diego, California, with resources throughout the U.S. and at
key strategic military locations.
Company:               MediaNet Group Technologies,
                   Inc.
Ticker Symbol & Exchange:       (OTCBB: MEDG)
Investor Relations Contact:      Martin Berns
Investor Relations Contact Phone:   954-974-5818 ext. 202
Web:                 www.medianetgroup.com
Date of Presentation:         8/19/08 12:30 p.m. PST
MediaNet Group Technologies, Inc. (OTCBB: MEDG), through its BSP
Rewards division, has developed the Internet's largest mall and
affinity program platform. BSP builds, brands, customizes and
administers proprietary loyalty/rewards/mall programs for each client
and organization and is also a value added element layered onto debit
and stored value cards. BSP Rewards creates private branded versions
of the mall for clients that enroll their database of members and
they then promote the mall to their members. Benefits to clients
include customer acquisition, incentive and retention, loyalty
programs, enhanced sales and potential new and recurring revenue--
turning operational costs into profit centers.
Company:               Merit Medical Systems, Inc.
Ticker Symbol & Exchange:       NASDAQ: MMSI
Investor Relations Contact:      Anne-Marie Wright
Investor Relations Contact Phone:   (801) 208-4167
Web:                 www.merit.com
Date of Presentation:         8/18/2008
Founded in 1987, Merit Medical Systems, Inc. is engaged in the
development, manufacture and distribution of proprietary disposable
medical devices used in interventional and diagnostic procedures,
particularly in cardiology and radiology. Merit serves client
hospitals worldwide with a domestic and international sales force
totaling approximately 90 individuals. Merit employs approximately
1,600 people worldwide, with facilities in Salt Lake City and South
Jordan, Utah; Angleton, Texas; Richmond, Virginia; Maastricht and
Venlo, The Netherlands; and Galway, Ireland.
Company:               Misonix, Inc.
Ticker Symbol & Exchange:       Nasdaq: MSON
Investor Relations Contact:      Kevin McGrath
Investor Relations Contact Phone:   212-245-4577
Web:                 www.misonix.com
Date of Presentation:         August 19, 2008 at 8:30am PT
Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures and
markets therapeutic ultrasonic medical devices and laboratory
equipment. Misonix's therapeutic ultrasonic platform is the basis for
several innovative medical technologies. These devices include High
Intensity Focused Ultrasound for the treatment of tumors, soft tissue
aspirators, laparoscopic cutting and coagulation instruments, and
surgical aspirators. Addressing a combined market estimated to be in
excess of $3 billion annually; Misonix's proprietary ultrasonic
medical devices are used for wound debridement, cosmetic surgery,
spinal surgery, neurosurgery, laparoscopic surgery, and other
surgical and medical applications.
Company:               MTR Gaming
Ticker Symbol & Exchange:       (NASDAQ:MNTG)
Investor Relations Contact:      Melissa Dixon
Investor Relations Contact Phone:   212-836-9613
Web:                 www.mtrgaming.com
Date of Presentation:         8/18/2008
MTR Gaming Group, Inc., through subsidiaries, owns and operates
Mountaineer Casino, Racetrack & Resort in Chester, WV; Presque Isle
Downs & Casino in Erie, PA; and Scioto Downs in Columbus, OH. The
Company also owns a 90% interest in Jackson Trotting Association,
LLC, which operates Jackson Harness Raceway in Jackson, MI, and a 50%
interest in the North Metro Harness Initiative, LLC, which operates
Running Aces Harness Park in Minneapolis, MN. Running Aces Harness
Park racetrack commenced racing in April 2008 and opened a 50-table
card room on June 30, 2008. For more information, please visit
www.mtrgaming.com.
Company:               National Lampoon
Ticker Symbol & Exchange:       NLN AMEX
Investor Relations Contact:      Howard Gostfriend
Investor Relations Contact Phone:   305-918-7000
Web:                 info@amcapventures.com
Date of Presentation:         8/18/2008
National Lampoon, Inc. has been a dominant force in the comedy world
for almost 40 years, and is currently active in a broad array of
media and entertainment segments. These include feature films,
Internet and online entertainment, television programming, home
video, audio, and book publishing. The Company also owns interests in
all major National Lampoon properties, including National Lampoon's
Animal House, the National Lampoon Vacation series and National
Lampoon's Van Wilder. National Lampoon reaches nearly one in four of
all 18 to 24 year old college students in America today. These
include the National Lampoon Humor Network - the most trafficked
humor sites on the web, the Drunk University Network, the new ZAZ
Network, and the National Lampoon Video Network, which includes
channels on YouTube, Yahoo, Veoh, and Lycos.
Company:               Neogenomics, Inc.
Ticker Symbol & Exchange:       OTCBB: NGNM
Investor Relations Contact:      Neogenomics
Investor Relations Contact Phone:   Steven Jones - (239) 325-2001
Web:                 www.neogenomics.org
Date of Presentation:         Monday, Aug. 18, 2008 1:30 p.m.
NeoGenomics, is a high-complexity CLIA-certified clinical laboratory
that specializes in cancer genetics diagnostic testing, the fastest
growing segment of the laboratory industry. The company's testing
services include cytogenetics, fluorescence in-situ hybridization
(FISH), flow cytometry, morphology studies, anatomic pathology and
molecular genetic testing. Headquartered in Fort Myers, FL,
NeoGenomics also has labs in Nashville, Tenn. and Irvine, Calif. and
services the needs of pathologists, oncologists, urologists, and
hospitals throughout the United States.
Company:               Novelos Therapeutics, Inc.
Ticker Symbol & Exchange:       NVLT OTCBB
Investor Relations Contact:      Stephen Lichaw
Investor Relations Contact Phone:   201-240-3200
Web:                 www.novelos.com
Date of Presentation:         August 18, 2008, 11am PDT
Novelos is a biopharmaceutical company commercializing oxidized
glutathione-based compounds for the treatment of cancer and
hepatitis. NOV-002, the lead compound currently in Phase 3
development for lung cancer under a SPA and Fast Track, acts together
with chemotherapy as a chemoprotectant and a chemopotentiator. NOV-
002 is also in Phase 2 development for chemotherapy-resistant ovarian
cancer and early-stage breast cancer. NOV-205 acts as a
hepatoprotective agent with immunomodulating and anti-inflammatory
properties. NOV-205 is in Phase 1b development for chronic hepatitis
C non-responders. Both compounds completed clinical trials in humans
and were approved in Russia where they were originally developed.
Company:               OmniComm Systems, Inc.
Ticker Symbol & Exchange:       OMCM.OB
Investor Relations Contact:      Ronald Linares, CFO
Investor Relations Contact Phone:   Ronald Linares, CFO 954-473-1254
Web:                 www.omnicomm.com
Date of Presentation:         Tuesday, August 19, 2008 at 7:30
                   AM
OmniComm Systems, Inc. is an eClinical software and services company
dedicated to helping pharmaceutical, biotechnology, CRO, research and
medical device organizations to maximize the value of their clinical
research investments through the use of innovative and progressive
technologies. The company has corporate headquarters located in Ft.
Lauderdale, Florida and offices in Bonn, Germany, Tula, Russia,
California, Maryland, New York, North Carolina and Texas. Founded in
1997, with a systems integration focus and an EDC solution built for
clinical research conducted at Mt. Sinai Hospital, we have continued
to develop our product pipeline and services to meet the evolving
needs of the drug development marketplace.
Company:               PHC, Inc. d/b/a Pioneer
                   Behavioral Healt
Ticker Symbol & Exchange:       AMEX: PHC
Investor Relations Contact:      Liolios Group
Investor Relations Contact Phone:   (949) 574-3860
Web:                 www.phc-inc.com
Date of Presentation:         August 19 at 7:30 a.m. Pacific
                   Time
PHC, Inc. d/b/a Pioneer Behavioral Health is an emerging national
healthcare company providing behavioral health services through
contracts with government agencies, national insurance companies, as
well as major transportation and gaming companies.
Pioneer to helps people gain and maintain physical, spiritual and
emotional health. The company achieves this by developing and
delivering the highest quality, most culturally responsive,
compassionate and competitive services to individuals, corporations,
and the community.
Pioneer operates in three complementary business operating units:
hospital and clinical services; integrated delivery services; and
clinical research.
Company:               Pipex Pharmaceuticals, Inc.
Ticker Symbol & Exchange:       AMEX: PP
Investor Relations Contact:      Thomas Redington
Investor Relations Contact Phone:   203-222-7399
Web:                 www.pipexinc.com
Date of Presentation:         8/18/2008
Pipex Pharmaceuticals, Inc. is a specialty pharmaceutical company that
is developing proprietary, late-stage drug candidates for the
treatment of central nervous system (CNS) and autoimmune diseases.
Pipex's strategy is to exclusively in-license proprietary, clinical-
stage drug candidates and to complete the further clinical testing,
manufacturing and regulatory requirements and seek marketing
authorizations. Pipex is focused on treating Dry Age-Related Macular
Degeneration (AMD), multiple sclerosis (MS), Rheumatoid Arthritis
(RA) and fibromyalgia.
Company:               Pluristem Therapeutics, Inc.
Ticker Symbol & Exchange:       PSTI: NASDAQ
Investor Relations Contact:      William R. Prather RPh, MD
Investor Relations Contact Phone:   303-883-4954
Web:                 Pluristem.com
Date of Presentation:         8/19/2008
Pluristem Therapeutics Inc. is dedicated to the commercialization of
non-personalized (allogeneic) cellular therapeutics for degenerative,
ischemic and autoimmune indications. The Company's pipeline of
products, stored ready-to-use and without HLA matching needed, are
derived from the human placenta, a non-controversial, non-embryonic,
adult stem cell source.
These placental cells are expanded in the Company's proprietary
PluriXTM 3D bioreactor, emulating bone-marrow, and not requiring
supplemental growth factors. Pluristem believes that the resultant
PLX (PLacental eXpanded) cells are able to differentiate into a
variety of cell types.
Pluristem's first product, PLX-PAD, to treat limb ischemia, enters
human trials in the fall of 2008.
Company:               Point.360
Ticker Symbol & Exchange:       PTSX - NASDAQ Global
Investor Relations Contact:      Alan Steel
Investor Relations Contact Phone:   818-565-1444
Web:                 asteel@point360.com
Date of Presentation:         8/18/2008
Point.360 is a value add service organization specializing in content
creation, manipulation and distribution processes integrating complex
technologies to solve problems in the life cycle of Rich Media. With
six locations in greater Los Angeles, Point.360 performs high and
standard definition audio and video post production, creates virtual
effects and archives and distributes physical and electronic Rich
Media content worldwide, serving studios, independent producers,
advertising agencies, corporations, non-profit organizations and
governmental agencies.
Company:               PokerTek, Inc.
Ticker Symbol & Exchange:       PTEK (NASDAQ)
Investor Relations Contact:      Mark Roberson
Investor Relations Contact Phone:   (704) 84-0860, x101
Web:                 www.pokertek.com
Date of Presentation:         8/18/2008
PokerTek, Inc. (NASDAQ: PTEK ) is the industry pioneer and worldwide
leader in automated poker tables and related software.
PokerTek develops and markets PokerPro automated poker tables and
related software applications developed to increase casino revenue,
reduce expenses and attract new players into poker rooms. PokerTek
also entered the amusement space by introducing Heads-Up
Challenge(TM), a heads-up poker table for bars and restaurants that
targets adults who play for amusement only.
PokerPro tables are located in the United States, Canada, Panama,
Germany, Australia, Bulgaria, South Africa and several major cruise
lines.
Company:               SmartPros Ltd.
Ticker Symbol & Exchange:       SPRO
Investor Relations Contact:      Shane Gillispie
Investor Relations Contact Phone:   914-752-4401
Web:                 www.smartpros.com
Date of Presentation:         8/19
Founded in 1981, SmartPros Ltd. is an industry leader in the field of
accredited professional education and corporate training. Its
products and services are primarily focused in the accredited
professional areas of corporate accounting, financial management,
public accounting, governmental and not-for-profit accounting,
financial services, banking, engineering, legal, ethics and
compliance, and information technology. SmartPros is a leading
provider of professional education products to Fortune 500 companies,
as well as the major firms and associations in each of its
professional markets. SmartPros provides education and content
publishing and development services in a variety of media including
Web, CD-ROM and video.
Company:               Synergetics USA, Inc.
Ticker Symbol & Exchange:       SURG
Investor Relations Contact:      Pamela G. Boone
Investor Relations Contact Phone:   636-794-5018
Web:                 www.synergeticsusa.com
Date of Presentation:         8/19/2008
Synergetics USA, Inc. is a leading medical device company focused on
progressing the standard of care for microsurgeons and their
patients. The Company seeks to improve surgical patient outcomes
through the delivery of product innovations related to improvements
in quality, delivery and cost by focusing on ophthalmology and
neurosurgery. Its distribution channels include a combination of
direct and independent sales organizations and important strategic
alliances with market leaders. The Company's product lines focus upon
precision engineered, microsurgical, hand-held instruments and the
microscopic delivery of laser energy, ultrasound, electrosurgery,
illumination and irrigation, often delivered in multiple
combinations.
Company:               TeleCommunication Systems, Inc.
Ticker Symbol & Exchange:       NASDAQ GM: TSYS
Investor Relations Contact:      Liolios Group
Investor Relations Contact Phone:   949-574-3860
Web:                 www1.telecomsys.com/
Date of Presentation:         8/19/2008
TeleCommunication Systems, Inc. (TCS) engineers and delivers highly
reliable wireless communications technology.
TCS provides wireless and VoIP E9-1-1 network-based services, secure
deployable communication systems, engineered satellite-based
services, and commercial location applications, like traffic and
navigation, using the precise location of a wireless device.
Customers include leading wireless, cable and VoIP carriers around the
world and agencies of the U.S. Departments of Defense, State, and
Homeland Security.
TCS is one of six primary vendors on a $5 billion Army Worldwide
Satellite Systems Contract vehicle. Its 500 employees are based
primarily in Annapolis, Seattle, Oakland, and Tampa.
Company:               The Quantum Group, Inc.
Ticker Symbol & Exchange:       AMEX: QGP
Investor Relations Contact:      Danielle Amodio
Investor Relations Contact Phone:   561.798.9800
Web:                 www.QuantumMD.com
Date of Presentation:         8/18/2008
The Quantum Group provides business process solutions, service chain
management, strategic consulting and leading edge technology
innovations to the healthcare industry. We are guided by a mission to
develop efficiencies, improve the quality of patient care and achieve
cost reductions for the nation's largest and fastest growing
industry. We have developed leading-edge technology with the creation
and deployment of a series of innovative patent-pending initiatives.
Through approximately 2,000 healthcare providers and multiple
insurance company relationships under management, we are positioned
to be a catalyst for change to the Florida healthcare industry.
Company:               Tix Corporation
Ticker Symbol & Exchange:       NasdaqCM: TIXC
Investor Relations Contact:      Elin Chistyakov
Investor Relations Contact Phone:   310-954-1110
Web:                 elin.chistyakov@icrinc.com
Date of Presentation:         Tuesday, August 19
Tix Corporation is an integrated entertainment organization offering
discount ticketing through its Tix4Tonight operation in Las Vegas,
where it dominates that market and is expanding nationally; premium
ticketing services; event merchandising such as owning and operating
the museum stores for the traveling King Tut exhibits; and live
theatrical production and promotion throughout the US and Canada. In
the first quarter of 2008, revenue increased to a record $23.2
million from $1.75 in the prior year period, and net income was
$461,000, or $0.01 per diluted share. The Company had a positive cash
flow from operations in the amount of approximately $2.6 million, a
cash balance of $6.6 million and no debt at March 31, 2008.
Company:               TMNG Global
Ticker Symbol & Exchange:       Nasdaq: TMNG
Investor Relations Contact:      Corey Kinger
Investor Relations Contact Phone:   212-986-6667
Web:                 www.tmng.com
Date of Presentation:         8/19/08
TMNG Global (NASDAQ: TMNG) is a leading provider of professional
services to the converging communications industry. Its companies,
TMNG, CSMG, Cartesian, and TWG Consulting, and its base of over 600
consultants, have provided strategy, management, and technical
consulting, as well as products and services, to more than 1200
communications service providers, entertainment, media, and
technology companies and financial services firms worldwide. The
company is headquartered in Overland Park, Kansas, with offices in
Boston, Chicago, London, New Jersey, New York, Shanghai and
Washington, D. C.
Company:               Tri-Isthmus Group, Inc.
Ticker Symbol & Exchange:       Pink Sheets: TISG
Investor Relations Contact:      Hawk Associates
Investor Relations Contact Phone:   Antonella Montagna - (305) 451-
                   1888
Web:                 www.tig3.com
Date of Presentation:         Monday, August 18, 1:30 p.m.
TIGroup partners with and provides financial, operational and
technological services to physician-owned businesses. The company
promotes quality medical care, efficiency and profitability for their
physician-partners and investors. Their services improve access,
quality and breadth of healthcare services in non-urban markets.
TIGroup is building a diversified portfolio of interests in
healthcare services operations, including rural hospitals, physician
practices, clinics, and ambulatory surgical centers. The Los Angeles-
based company operates several medical facilities and employs over
300 people in Oklahoma and California.
Company:               Zix Corporation
Ticker Symbol & Exchange:       Nasdaq: ZIXI
Investor Relations Contact:      Peter Wilensky
Investor Relations Contact Phone:   214-515-7357
Web:                 www.zixcorp.com
Date of Presentation:         8/19/2008
ZixCorp is a leading provider of hosted Internet applications, offered
in a Software as a Service (SaaS) model, that require high
availability, reliability, integrity, and -- particularly --
security. We currently target two lines of business: ZixCorp's hosted
Email Encryption Service provides an easy and cost-effective way to
ensure customer privacy and regulatory compliance for corporate
email. Its PocketScript(R) e-prescribing service saves lives and
saves money by automating the prescription process between payors,
doctors and pharmacies, and provides a platform for additional
functionality by creating a real-time connection to physicians at the
point of care.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.

[ Back To TMCnet.com's Homepage ]